Pricing Log in Create free account
Saturday 17 October 2026 Export RMD’s income statement to Excel — free account

ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

238.97 3.26 −1.35%
Market cap
$34.1B
P/E
22.8×
Fwd P/E
16.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

ResMed Inc. (RMD) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, ResMed Inc. (RMD) trades at a EV/EBITDA of 15.8×. Over the past ten years it has ranged from 11.7× (June 2026) to 39.8× (September 2021); the current reading is higher than 10% of that period. That is above the Medical Instruments & Supplies industry median of 14.6× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2026 12.8× (34.04%)
FY2025 19.4× 6.74%
FY2024 18.2× (27.31%)
FY2023 25.0× (3.94%)
FY2022 26.1× (21.11%)
FY2021 33.0× 15.19%
FY2020 28.7× 11.20%
FY2019 25.8× 14.54%
FY2018 22.5× 7.50%
FY2017 20.9× 19.88%

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 12.8× (11.98%)
Mar 2026 14.6× (11.92%)
Dec 2025 16.5× (16.03%)
Sep 2025 19.7× 1.33%
42 more quarters

Against its own ten years

Low 11.7× High 39.8×
Ten-year median 21.7×
Current reading's percentile 10

EV/EBITDA against peers

Company EV/EBITDA
MDLN Medline Inc. compare 4.1×
SOLV Solventum Corporation compare 7.6×
ALC Alcon compare 13.0×
BDX Becton, Dickinson and Company compare 13.7×
BAX Baxter International Inc. compare 14.0×
COO The Cooper Companies, Inc. compare 14.6×
RMD ResMed Inc. 15.8×
WST West Pharmaceutical Services, Inc. compare 31.2×
RGEN Repligen Corporation compare 60.2×
Medical Instruments & Supplies industry median 14.6×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on RMD